Literature DB >> 19282767

Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.

Ai-Min Xu1, Zhi-Hong Xian, Shu-Hui Zhang, Xin-Fang Chen.   

Abstract

Multiple bile duct hamartomas (BDHs)/von Meyenburg complexes, are tumor-like lesions of the liver. Malignant transformation in BDHs has been previously reported in very rare instances, and the most common tumor arising in this clinical setting is cholangiocarcinoma. Herein, we report on clinicopathological findings in two cases of cholangiocarcinoma occurring in liver with multiple BDHs. Histopathologically, multiple BDHs showed morphologic transition from clearly benign to dysplasia or carcinoma in situ, then to invasive carcinoma sequence of the biliary epithelium. The neoplastic epithelium showed positivity for cytokeratin 19, CA 19-9, and epithelial membrane antigen. Staining for Hep Par 1, alpha-fetoprotein, cytokeratin 20, and alpha1-antitrypsin was negative. All sections from the non-neoplastic liver in each specimen showed multiple BDHs. Any other clinically detectable primary tumor was not found. These two neoplasms were interpreted as a cholangiocarcinoma arising in BDHs. This suggested BDHs might be a risk factor of development of cholangiocarcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19282767     DOI: 10.1097/MEG.0b013e3282fc73b1

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  16 in total

1.  Multiple bile duct hamartomas mimicking diffuse hepatic metastasis: GI image.

Authors:  Ashish Singhal; Rajesh Kanagala; Harlan I Wright; Vivek Kohli
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

2.  Biliary hamartoma presented as a single mass.

Authors:  Yong Moon Shin
Journal:  Korean J Hepatol       Date:  2011-12

3.  Cholangiocarcinoma arising in von Meyenburg complexes.

Authors:  Hee Kyung Kim; So-Young Jin
Journal:  Korean J Hepatol       Date:  2011-06

4.  Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.

Authors:  Michael R O'Dell; Jing Li Huang; Christa L Whitney-Miller; Vikram Deshpande; Paul Rothberg; Valerie Grose; Randall M Rossi; Andrew X Zhu; Hartmut Land; Nabeel Bardeesy; Aram F Hezel
Journal:  Cancer Res       Date:  2012-01-20       Impact factor: 12.701

5.  Adenoma-carcinoma sequence in intrahepatic cholangiocarcinoma.

Authors:  André Costa Pinho; Renato Bessa Melo; Manuel Oliveira; Marinho Almeida; Joanne Lopes; Luís Graça; J Costa-Maia
Journal:  Int J Surg Case Rep       Date:  2012-01-18

6.  Surgery is the preferred treatment for bile duct hamartomas.

Authors:  Xiao-Yu Yang; Hai-Bo Zhang; Bin Wu; Ai-Jun Li; Xiao-Hui Fu
Journal:  Mol Clin Oncol       Date:  2017-07-31

7.  Imaging findings of bile duct hamartomas: a case report and literature review.

Authors:  Qiu-Sheng Shi; Ling-Xi Xing; Li-Fang Jin; Han Wang; Xiu-Hong Lv; Lian-Fang Du
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

Authors:  Mark Ettel; Ogechukwu Eze; Ruliang Xu
Journal:  World J Hepatol       Date:  2015-11-08

9.  Computed tomography and magnetic resonance imaging findings in a case with biliary microhamartomas.

Authors:  Alper Dilli; Umit Yasar Ayaz; Ilhami Yüksel; Cagrı Damar; Sevin Ayaz; Baki Hekimoglu
Journal:  Case Rep Med       Date:  2012-01-31

Review 10.  Development of the bile ducts: essentials for the clinical hepatologist.

Authors:  Mario Strazzabosco; Luca Fabris
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.